stockrow
Friday 6 November 2026
Export RGC’s income statement to Excel — free account
Regencell Bioscience Holdings Limited
RGC Healthcare Drug Manufacturers Specialty & Generic
5.16
0.26
−4.80%
Follow RGC
Alert me
Regencell Bioscience Holdings Limited (RGC) Return on equity
Regencell Bioscience Holdings Limited's return on equity over the twelve months to 30 June 2026 was 0.00%. Over the past ten years it has ranged from −128.5% (fiscal 2026) to 40.5% (fiscal 2021) — the current reading is the lowest in ten years. That is above the Drug Manufacturers Specialty & Generic industry median of −0.80% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2026 | −128.5% | (73.71) |
| FY2025 | −54.8% | (12.23) |
| FY2024 | −42.6% | (2.19) |
| FY2023 | −40.4% | 73.43 |
| FY2022 | −113.8% | (154.33) |
| FY2021 | 40.5% | 4.32 |
| FY2020 | 36.2% | 18.77 |
| FY2019 | 17.4% | — |
Against its own ten years
Low −128.5%
High 40.5%
Ten-year median
−41.5%
Current reading's percentile
13
Return on equity against peers
| Company | Return on equity |
|---|---|
| BCRX BioCryst Pharmaceuticals, Inc. compare | 91.6% |
| PBH Prestige Consumer Healthcare Inc. compare | 8.23% |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | 0.00% |
| RGC Regencell Bioscience Holdings Limited | 0.00% |
| ALVO Alvotech compare | 0.00% |
| XERS Xeris Biopharma Holdings, Inc. compare | −27.1% |
| TRLV Trulieve Cannabis Corp. compare | −45.5% |
| PRGO Perrigo Company plc compare | −51.4% |
| AMLX Amylyx Pharmaceuticals, Inc. compare | −74.7% |
| Drug Manufacturers Specialty & Generic industry median | −0.80% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)